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Microalbuminuria, an indicator of glomerular injury, is
associated with increased risk of progressive renal
deterioration, cardiovascular disease, and mortality. However,
the prevalence of microalbuminuria in Japanese general
population is less certain. Thus, we examined the prevalence
of microalbuminuria and its associated risk factors in Japan.
Subjects of this cross-sectional study were asymptomatic
individuals over 40 years in Takahata, Japan. Urine
albumin–creatinine ratio was calculated from a single-spot
urine specimen collected in the morning. Creatinine
clearance (CCr) was obtained by Cockcroft–Gault equation.
Multivariate logistic regression analysis was used to
determine which risk factors (i.e., age, hypertension, diabetes,
obesity, and salt intake) might predict the presence of
microalbuminuria. A total of 2321 subjects (mean age, 64
years; men, 1034; women, 1287) were entered into the final
analysis. Among them, the prevalence of microalbuminuria,
macroalbuminuria, and proteinuria by dipstick test (X1þ )
were 317 (13.7%), 39 (1.7%), and 103 (4.4%), respectively.
Age, hypertension, and diabetes were independently
associated with microalbuminuria in men. In addition to the
classical risk factors detected in men, estimated 24-h urinary
sodium excretion and uric acid were also independently
associated with microalbuminuria in women. Among the 668
subjects with renal insufficiency (CCr o60 ml/min/1.73 m2),
the prevalence of microalbuminuria and macroalbuminuria
were 119 (17.8%) and 18 (2.7%), respectively. In conclusion,
microalbuminuria is prevalent across all age groups and is
associated with lifestyle-related risk factors in Japanese
general population. However, there are a substantial number
of subjects with renal insufficiency accompanying no
microalbuminuria.
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During recent years, epidemiological studies revealed that the
number of patients affected by chronic kidney disease (CKD)
has increased worldwide. It resulted in the steady increase
of patients with end-stage renal disease treated by dialysis or
renal transplantation. Japan is one of the countries with
the highest incidence rate of end-stage renal disease. In 2003,
the number of Japanese end-stage renal disease patients has
reached to 237 710 and is still growing.1 Recent progresses in
pharmacological and nutritional therapy for patients with
CKD have suggested that early detection and appropriate
treatment may reduce the incidence of end-stage renal
disease.2–4 However, CKD, especially at its early stage, is
unlikely to show apparent symptoms and is easily over-
looked. Thus, it is necessary to establish the appropriate
method to detect the silent CKD.
The microalbuminuria is reported to be associated with a
higher incidence of cardiovascular complication in the
general population.5,6 The appearance of microalbuminuria
also predicts an increased risk of cardiovascular and all-cause
mortality in patients with hypertension and diabetes.7,8
Several studies have disclosed that risk factors for presence
of microalbuminuria includes age, hypertension, hypergly-
cemia, smoking, male gender, C-reactive protein, white blood
cell counts,9 and hypercholesterolemia.10 However, these
results concerning the microalbuminuria were mostly
obtained from data based on non-Asian population. There-
fore, we undertook the population-based study to examine
the prevalence of microalbuminuria and its risk factors in
Takahata, Japan.
RESULTS
Characteristics of subjects
Baseline characteristics of 2321 subjects who entered into
final analysis were shown in Table 1. Overall, mean age was
64 years. Among them, there were 1034 men (44.5%), 1323
subjects (57.0%) with hypertension, 722 subjects (31.1%)
with obesity, 201 subjects (8.7%) with diabetes, 757 subjects
(32.6%) with hypercholesterolemia, and 317 subjects (13.7%)
with microalbuminuria. Average of 24-h urinary sodium
excretion estimated by Kawasaki’s formula was 209.1 mEq/
day. Age, systolic blood pressure, diastolic blood pressure,
serum creatinine, estimated 24-h urinary sodium excretion,
fasting blood sugar, uric acid, urine creatinine, percentage of
diabetes, current smoking, and drinking were significantly
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higher in men compared to women. The creatinine clearance
(CCr) and the percentage of hypercholesterolemia were
higher in women compared to men.
Prevalence of microalbuminuria
In the general population, microalbuminuria was prevalent
across all age groups and the proportion of subjects with
microalbuminuria increases with age (Figure 1).
Among the 2321 subjects who were asymptomatic aged
over 40 years, the prevalence of microalbuminuria, macro-
albuminuria, and proteinuria by dipstick test (X1þ ) were
317 (13.7%), 39 (1.7%), and 103 (4.4%), respectively
(Table 2). The prevalence of proteinuria is about one-third
of that of microalbuminuria. Sensitivity and specificity of
urinary protein dipstick test (X1þ ) for micro- or macro-
albuminuria (urine albumin–creatinine ratio (UACR)
X30 mg/g) was 26.8 and 99.6%, respectively.
Relationship between microalbuminuria and renal
insufficiency
Next, we investigated the relationship between microalbumi-
nuria and renal insufficiency. In total, the prevalence of the
subjects with normal or increased CCr (X90 ml/min/
1.73 m2), mildly decreased CCr (60–89 ml/min/1.73 m2),
and moderately or severely decreased CCr (o60 ml/min/
1.73 m2) were 7.6, 63.6, and 28.8%, respectively. The
percentage of renal insufficiency was increasing along with
age. Table 2 shows that among the 668 subjects with moder-
ate or severe renal insufficiency (CCr o60 ml/min/1.73 m2),
the prevalence of normoalbuminuria, microalbuminuria,
and macroalbuminuria were 531 (79.5%), 119 (17.8%),
and 18 (2.7%), respectively. On the contrary, among the
1653 subjects with relatively preserved CCr (X60 ml/min/
1.73 m2), the prevalence of normoalbuminuria, microalbu-
minuria, and macroalbuminuria were 1434 (86.7%), 198
(12.0%), and 21 (1.3%), respectively.
Risk factors for microalbuminuria
Next, we examined the relationship between the presence of
microalbuminuria and risk factors. The distribution of UACR
among study subjects was highly skewed toward the larger
values. The 25, 50, and 75th percentile values of UACR were
5.1, 8.1, and 18.1 mg/g in men, and 6.8, 10.1, and 19.0 mg/g
in women, respectively. We categorized UACR into quartiles
and then compared the mean value or percentage of
risk factors in each quartile. Table 3 showed that age, systolic
and diastolic blood pressure, body mass index, the percentage
of hypertension, diabetes, estimated 24-h urinary sodium
Table 1 | Comparisons of baseline characteristics between
men and women
Men Women
Number 1034 1287
Age (years) 64.2710.2a 63.3710.0
Systolic BP (mm Hg) 136.4715.4a 132.7715.8
Diastolic BP (mm Hg) 81.779.6a 76.679.4
BMI (kg/m2) 23.473.0 23.673.4
Hypertension (%) 59.1 55.2
Obesity (%) 31.0 31.2
Smoker (%) 61.0a 7.7
Drinker (%) 72.3a 14.4
Diabetes (%) 10.5a 7.1
Hypercholesterolemia (%) 22.9a 40.4
Microalbuminuria (%) 14.5 12.9
Serum creatinine (mg/dl) 0.7870.26a 0.5970.12
Serum total cholesterol (mg/dl) 192.7730.8 206.8730.3
Estimated 24-h urinary sodium
excretion (mEq/day)b
218.7760.9a 200.7752.3
Fasting blood sugar (mg/dl) 93.0728.6a 85.2727.3
Uric acid (mg/dl) 5.7471.30a 4.4971.08
CCr/BSA (ml/min/1.73 m2) 67.8714.9a 69.4715.0
Urine creatinine (g/l) 1.3370.67a 1.0370.53
Urine albumin (mg/l) 10.5 (0.8–6146.0) 10.2 (0.6–2429.5)
BMI, body mass index; BP, blood pressure; BSA, body surface area; CCr, creatinine
clearance.
aPo0.05 men vs women.
bEstimated 24-h urinary sodium excretion from the spot urine. Urine albumin is
expressed as median with range (min–max).
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Figure 1 | Distribution of micro- and macroalbuminuria by age in (a) men and (b) women.
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excretion, fasting blood sugar, and serum albumin were
associated with increasing levels of UACR in men. In addition
to the risk factors detected in men, obesity, drinking, and uric
acid were also associated with UACR levels in women
(Table 4).
To examine the contribution of risk factors in the presence
of microalbuminuria, we used a multiple logistic regression
analysis. Age, hypertension, and diabetes were independently
associated with the presence of microalbuminuria in men. In
women, age, hypertension, diabetes, estimated 24-h urinary
sodium excretion, uric acid, and serum albumin were
independently associated with microalbuminuria (Table 5).
DISCUSSION
In asymptomatic subjects of Japanese general population,
microalbuminuria is prevalent across all age groups. The
prevalence of microalbuminuria in all participants was
13.7%. This value is within the range of previous reports in
Japan (13.2–19.6%).11,12 However, our result is higher than
those of other studies, for example, 7% in the Netherlands,13
8.3% in National Health and Nutrition Examiniations
Surveys,14 and 6.0% in Australia.15 Several factors including
differences in the method to collect urinary samples and
diagnosis criteria might affect the results in these studies.
Another possible explanation for the higher rate of micro-
albuminuria in our study might be the age of subjects. Our
target subjects (over 40 years) were older than those of other
studies that include younger generation. Of note, Weir16 has
reported that the Asian incidence of microalbuminuria
(40%) in hypertensive diabetic patients is substantially higher
than what is seen in North America and Europe (16–29%).
Therefore, there is a possibility that Asian population
including Japanese might be susceptible to microalbuminuria
as compared with the population in North America and
Europe.
Among all subjects, the prevalence of proteinuria (X1þ )
by urine dipstick test was 4.4%. The prevalence of micro- or
macroalbuminuria was 13.7 and 1.7%, respectively. The
percentage of positive result by urine dipstick test for protein
is about one-third of that of microalbuminuria. This result
indicates that the sensitivity of urine dipstick test might not
be enough to detect the renal glomerular damage at early
stage. Accordingly, the measurement of microalbuminuria
should be recommended as an indicator of glomerular injury.
Table 2 | Prevalence of microalbuminuria, macroalbuminuria, and proteinuria according to estimated CCr
Estimated CCr (ml/min/1.73 m2) N (%) Microalbuminuria (%) Macroalbuminuria (%) Proteinuria (%)
X90 176 (7.6) 23 (13.0) 3 (1.7) 10 (5.7)
60–89 1477 (63.6) 175 (11.8) 18 (1.2) 56 (3.8)
o60 668 (28.8) 119 (17.8) 18 (2.7) 37 (5.5)
Total 2321 317 (13.7) 39 (1.7) 103 (4.4)
CCr, creatinine clearance; UACR, urine albumin–creatinine ratio.
Microalbuminuria, UACR: 30–300 mg/g; macroalbuminuria, UACR 4300 mg/g; proteinuria, urine dipstick test X1+.
Table 3 | Comparisons of baseline characteristics among quartile groups classified by UACR levels in men
UACR quartile groups
Q1 Q2 Q3 Q4 P-value
Number 270 254 251 259
Age (years) 60.8710.3 64.579.9 64.979.8 66.879.7 o0.001
Systolic BP (mm Hg) 129.6714.5 135.2714.9 138.8713.6 142.5715.4 o0.001
Diastolic BP (mm Hg) 78.979.5 81.178.8 82.879.1 83.9710.1 o0.001
BMI (kg/m2) 23.072.9 23.272.8 23.772.8 23.873.3 0.0087
Hypertension (%) 42.5 55.5 66.1 73.4 o0.001a
Obesity (%) 25.6 29.5 33.5 35.9 NS
Smoker (%) 64.8 60.6 56.1 62.2 NS
Drinker (%) 72.9 73.6 72.1 70.6 NS
Diabetes (%) 7.8 7.1 9.6 17.7 o0.001a
Hypercholesterolemia (%) 21.1 25.2 21.5 24.0 NS
Serum creatinine (mg/dl) 0.7870.13 0.7670.16 0.7670.14 0.8170.14 NS
Serum total cholesterol (mg/dl) 191.9730.6 194.9728.3 191.9729.4 192.1734.4 NS
Estimated 24-h urinary sodium excretion (mEq/day)b 219.2760.0 209.5756.7 221.4760.3 224.7765.5 0.0311
Fasting blood sugar (mg/dl) 88.0724.1 93.9721.7 93.2728.7 96.9736.9 0.0042
Uric acid (mg/dl) 5.7671.2 5.7071.3 5.7071.4 5.8071.3 NS
Serum albumin (g/dl) 4.4870.3 4.5170.3 4.5670.24 4.5070.3 0.0032
CCr/BSA (ml/min/1.73 m2) 69.1713.8 67.7713.8 68.3714.5 65.8717.0 NS
Estimated 24-h urinary potassium excretion (mEq/day)b 58.8713.0 56.8712.1 58.1711.9 56.6712.1 NS
BMI, body mass index; BP, blood pressure; BSA, body surface area; CCr, creatinine clearance; NS, not significant; UACR, urine albumin–creatinine ratio.
One-factor ANOVA.
aw2 test.
bEstimated 24-h urinary sodium (potassium) excretion from the spot urine.
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The prevalence of subjects with moderate or severe renal
insufficiency (CCr o60 ml/min/1.73 m2) among all subjects
was 28.8% (CKD stages 3–5). This rate seems to be
remarkably higher than those in National Health and
Nutrition Examiniations Surveys III (8.8%),14 in AusDiab
Kidney study (11.2%)15 and in Icelandic study (men 4.7%,
women 11.6%).17 However, Iseki et al.18 reported that 25% of
general population has reduced CCr (o50 ml/min/1.73 m2)
in Okinawa, Japan. Thus, our result seems to be consistent
with previous report in Japan. Most of the recent studies
apply Modification of Diet in Renal Disease equation to
estimate glomerular filtration rate. However, Modification of
Diet in Renal Disease equation requires racial factor that has
not been established for Japanese population yet. Accord-
ingly, we did not apply Modification of Diet in Renal Disease
equation in this study. This point should be examined after
the establishment of racial factor for Japanese. The prevalence
of subjects with micro- or macroalbuminuria and more than
60 ml/min/1.73 m2 CCr was 9.4% (CKD stages 1–2). Thus, in
total, there were at least 38.2% of subjects with CKD (stages
1–5) in this population.
The association between silent kidney disease and
microalbuminuria has not been well depicted in Japan. Our
study showed that among the subjects with reduced CCr
(o60 ml/min/1.73 m2), 20.5% of subjects had micro- or
macroalbuminuria. It is noteworthy that the remaining
Table 4 | Comparisons of baseline characteristics among quartile groups classified by UACR levels in women
UACR quartile groups
Q1 Q2 Q3 Q4 P-value
Number 331 314 320 322
Age (years) 57.979.5 63.479.0 64.479.8 67.779.5 o0.001
Systolic BP (mm Hg) 125.5714.7 132.2714.3 133.8715.6 139.5715.3 o0.001
Diastolic BP (mm Hg) 73.578.8 76.778.7 77.179.7 79.379.3 o0.001
BMI (kg/m2) 23.273.0 23.373.2 23.473.4 24.673.8 o0.001
Hypertension (%) 37.5 51.6 59.1 73.3 o0.001a
Obesity (%) 25.9 28.0 27.5 43.1 o0.001a
Smoker (%) 11.8 6.7 5.9 6.2 0.0139a
Drinker (%) 20.2 13.1 13.4 10.6 0.0033
Diabetes (%) 2.4 5.4 5.9 14.9 o0.001a
Hypercholesterolemia (%) 39.9 39.5 38.8 43.5 NS
Serum creatinine (mg/dl) 0.6170.09 0.5870.09 0.5770.10 0.6070.16 o0.001
Serum total cholesterol (mg/dl) 205.8732.3 206.4731.4 206.8729.2 208.3728.2 NS
Estimated 24-h urinary sodium excretion (mEq/day)b 192.4750.6 201.1750.5 200.8750.4 208.7756.3 0.0012
Fasting blood sugar (mg/dl) 84.5720.4 83.7726.4 86.9724.4 85.8735.6 NS
Uric acid (mg/dl) 4.5571.0 4.4071.0 4.3271.0 4.6871.2 o0.001
Serum albumin (g/dl) 4.4770.23 4.5070.23 4.5270.23 4.5370.23 0.0015
CCr/BSA (ml/min/1.73 m2) 71.6713.4 69.7714.1 69.5714.9 66.7717.1 o0.001
Estimated 24-h urinary potassium excretion (mEq/day)b 54.4710.4 54.679.2 51.4710.5 53.879.8 NS
BMI, body mass index; BP, blood pressure; BSA, body surface area; CCr, creatinine clearance; NS, not significant; UACR, urine albumin–creatinine ratio.
One-factor ANOVA.
aw2 test.
bEstimated 24-h urinary sodium (potassium) excretion from the spot urine.
Table 5 | Multiple logistic regression model to predict microalbuminuria
Odds ratio (95% CI) P-value
Subjects
Men (n=1013)
Age (per 10-year increase) 1.273 (1.053, 1.539) 0.0126
Hypertension 2.072 (1.388, 3.091) o0.001
Diabetes 2.201 (1.354, 3.578) 0.0015
Serum albumin (per 0.3 g/dl increase) 1.042 (0.853, 1.272) NS
Estimated 24-h urinary sodium excretiona (per 60 mEq/day increase) 1.060 (0.890, 1.262) NS
Women (n=1269)
Age (per 10-year increase) 1.568 (1.285, 1.913) o0.001
Hypertension 2.062 (1.394, 3.052) o0.001
Obesity 1.251 (0.868, 1.805) NS
Smoker 1.001 (0.481, 2.083) NS
Drinker 1.318 (0.793, 2.189) NS
Diabetes 3.663 (2.194, 6.116) o0.001
Estimated 24-h urinary sodium excretiona (per 60 mEq/day increase) 1.255 (1.063, 1.482) 0.0074
Uric acid (per 1 mg/dl increase) 1.340 (1.145, 1.567) o0.001
Serum albumin (per 0.3 g/dl increase) 1.233 (1.031, 1.475) 0.0220
CI, confidence interval; NS, not significant.
aEstimated 24-h urinary sodium excretion from the spot urine.
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79.5% of subjects with reduced CCr did not accompany
microalbuminuria. Osicka and Comper19 reported the
existence of immunochemically nonreactive urinary albumin.
Thus, some of these cases might have predominantly excreted
an immunochemically nonreactive urinary albumin. How-
ever, in other cases, renal injury might not originate from
vascular endothelial damage of glomerulus. The mechanism
by which the renal insufficiency progresses in the latter
population should be elucidated further.
As risk factors for microalbuminuria, age, hypertension,
smoking, obesity, hyperglycemia, non-Caucasian ethnicity,
and hypercholesterolemia were reported previously.9,12,20 In
our study, besides such conventional risk factors, the increase
of sodium intake and uric acid was also associated with
microalbuminuria in women. It has been reported that the
excess of salt intake increases microalbuminuria in subjects
with diabetes and hypertension.21 However, the effect of salt
intake on microalbuminuria in general population has not
been well documented. Generally speaking, Japanese has a
genetically salt-sensitive constitution22 and higher sodium
intake than Caucasians. In northern part of Japan including
Takahata, the amount of daily salt intake is higher than the
average amount in Japanese population. Under such a
circumstance, the role of sodium intake for development of
microalbuminuria might be strengthened. This point will be
investigated in future.
The relationship between uric acid and microalbuminuria
in women is an interesting finding. Iseki et al.23 have shown
that increased serum uric acid level is associated with the
higher risk of developing renal insufficiency, especially in
women. In selected subjects such as diabetic and hypertensive
patients, hyperuricemia is known to increase microalbumi-
nuria.24 However, the association between uric acid and
microalbuminuria has not been confirmed in general
population. In this study, uric acid was independently
associated with increased level of microalbuminuria in
asymptomatic women. Increased level of uric acid induces
hypertension25 and uric acid per se impairs vascular
endothelial function.26 These mechanisms might play a role
for the development of microalbuminuria in this population.
There are several limitations in our study. First, the
measurement of microalbuminuria was carried out only
once, which did not completely conform to the requirement
of multiple urine collections for microalbuminuria.27 Second,
in this study, we used UACR with a single set of cutpoints for
men and women. Although this cutpoint is widely accepted,
it has a problem that incorrectly elevated albumin excretion
might be obtained in subjects with a low creatinine excretion
such as women or elderly. In lean Japanese population, there
is a possibility that a single measurement of UACR might
overestimate the prevalence of microalbuminuria. Another
problem in using UACR is that the usage of a creatinine
excretion in the denominator for UACR and body mass index
might weaken the associations between them. Third, sodium
intake was not assessed by 24-h urinary collection. These
parameters must have some fluctuation depending on the
survey time. Thus, it is desirable to repeat the measurement
of these parameters. In addition, this study is a population-
based cross-sectional study. To confirm the importance of
risk factors on renal outcome, it is necessary to follow-up the
prognosis of each group in the future.
The present study has shown that unrecognized kidney
disease with microalbuminuria is prevalent across all age
groups in general population in Japan. In addition to
conventional risk factors, salt intake and increased level of
uric acid might be associated with microalbuminuria in
Japanese female population. Although albuminuria might be
a sensitive indicator for glomerular injury, it should be noted
that there are a substantial number of cases with renal
insufficiency accompanying no microalbuminuria in this
population.
MATERIALS AND METHODS
Study population
This study is a part of the ongoing Molecular Epidemiological Study
utilizing the Regional Characteristics of 21st Century Centers of
Excellence Program in Japan. The aim of the present study is to
determine the prevalence and risk factor analysis of microalbumi-
nuria in general population in Japan. This study is a design-
incorporated baseline survey that consisted of a self-administered
questionnaire on lifestyle, blood pressure measurement, anthropo-
metrical measurement, and collections of blood and urine speci-
mens from participants in the morning.
The survey population in this study is the general population
over 40 years in Takahata, Japan. In 2004, 1055 men and 1346
women (total, 2401) took part in the program and agreed to join the
study. This study was approved by the institutional ethical
committee. All participants gave written informed consent.
Eighty subjects were excluded from the present analysis owing to
their incomplete data. A total of 2321 subjects entered into the final
statistical analysis as asymptomatic population. There were 1034
(44.5%) male and 1287 (55.5%) female subjects. Mean age was
64 years.
Measurement
Subjects used a self-reported questionnaire to document medical
history, current medication, family history, clinical symptoms,
smoking habits (current or non-smoker), and alcohol intake
(current or non-drinker). Systolic and diastolic blood pressures
were determined by using a mercury manometer, placed on the right
arm of seated subjects who had rested in a sitting position for at
least 5 min before the measurement. Measurement was performed
twice, with the mean value used for statistical analysis. Hypertension
was defined as systolic blood pressureX140 mm Hg and/or diastolic
blood pressure X90 mm Hg, and/or the use of anti-hypertensive
medication. Body mass index was calculated from weight and height
measures as weight (kg) divided by the square of height (m2).
Obesity was specified as body mass indexX25.0 kg/m2 both in men
and women.28 Diabetes was ascertained either by self-reported
physical diagnosis or by a measure of fasting blood sugarX126 mg/
dl or HbA1c valueX6.5%. Hypercholesterolemia was ascertained by
a measure of serum total cholesterol X220 mg/dl, and/or the use
of anti-hyperlipidemic medication. UACR was calculated from
a single-spot urine specimen collected in the morning. Urine
albumin concentration was determined by an immunoturbidimetry.
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Microalbuminuria and macroalbuminuria were defined as UACR
30–300 and 4300 mg/g, respectively by the National Kidney
Foundation.29 Subjects were excluded when menstruation is present,
because this makes albumin measurement unreliable. Proteinuria is
defined
by dipstick test of spot urine samples (positive; X1þ ). Serum
creatinine was measured by enzymatic method and CCr was
estimated using the Cockcroft–Gault equation,30 including a
correction factor of 0.85 for women and adjustment for body
surface area.31 Serum creatinine levels measured by enzymatic
method show a 0.25 mg/dl decrease compared with levels measured
by Jaffe’s method.18 To estimate CCr, we used adjusted serum
creatinine values. CCr was categorized as renal insufficiency
(o60 ml/min/1.73 m2).32 Twenty-four-hour urinary intake of so-
dium and potassium was estimated by Kawasaki’s equation using a
spot urine specimen.33
Statistical analyses
We used Student’s t-test to evaluate differences in means and w2 tests
to evaluate differences in proportions. For comparison of mean
values among quartiles, one-factor analysis of variance was used. To
test the independent relationships between microalbuminuria and
several continuous or categorical parameters, a multivariate logistic
regression analysis was used to estimate odds ratio and 95%
confidence intervals. We selected the representative variables that are
significant in a univariate analysis and might be related with the
induction of microalbuminuria: age, hypertension, obesity, diabetes,
smoking, drinking, uric acid, serum albumin, and estimated 24-h
urinary sodium excretion. Data are expressed as mean7s.d. All
statistical analyses were performed using the software of Stat View
version 5 (SAS Institute Inc., Cary, NC, USA). A significant
difference was defined as Po0.05.
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